Gemphire Therapeutics Receives $2,650,000 New Financing Round

  • Feed Type
  • Date
    12/23/2015
  • Company Name
    Gemphire Therapeutics
  • Mailing Address
    43334 Seven Mile Road Northville, MI 48167 USA
  • Company Description
    Our mission is to develop novel drugs, such as gemcabene, to treat the large, growing unmet need of dyslipidemia patients who are unable to reach optimal LDL cholesterol or triglyceride levels with statin or other therapies.
  • Website
    http://www.gemphire.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,650,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 52 investors participated in the original and amended offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing – amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy